Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy (HCMR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Virginia
National Heart, Lung, and Blood Institute (NHLBI)
Oxford University Hospitals NHS Trust
Information provided by (Responsible Party):
Christopher M. Kramer MD, University of Virginia Identifier:
First received: July 31, 2013
Last updated: May 11, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2018
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):